ArticlebioRxiv : the preprint server for biology2021
Nebulized delivery of a broadly neutralizing SARS-CoV-2 RBD-specific nanobody prevents clinical, virological and pathological disease in a Syrian hamster model of COVID-19.
Thomas J Esparza et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.